GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioWorld News, Courthouse News, Medical Xpress and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 67d ago.
Quick answers
Why is "GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Microbiota modulates the antidepressant effects of GLP-1 analogues BioWorld News · 91d ago
- Guts may hold the key to happiness Courthouse News · 91d ago
- GLP-1s may alleviate depression through the microbiome, mouse study suggests Medical Xpress · 91d ago
- GLP-1s may combat depression through a mood-boosting gut microbe Fierce Biotech · 91d ago
- GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria Neuroscience News · 91d ago
Topics
Related trends
Novel insight into the effects of the metabolites from gut microbiota in both unmedicated depressive adolescents and mice: key roles of indole derivatives-aryl hydrocarbon receptor signaling in neurogenesis and microglial homeostasis
Recent studies link gut bacteria and microbial metabolites to brain chemistry, depression risks, and neurogenesis.
Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
GLP-1 prescriptions for kids up more than 30,000% since 2019
Prescriptions for GLP-1 medications among children in the United States have surged by over 30,000% since 2019.
GLP-1 weight-loss drugs show promise for sleep apnea
Recent coverage highlights a potential new therapeutic benefit for GLP-1 weight-loss drugs regarding sleep apnea.
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Novo Nordisk faces a strategic divide as its childhood obesity drug succeeds in trials while its heart drug program suffers multiple terminations.